{
    "title": "107_hr2750",
    "content": "SECTION 1. SHORT TITLE; PURPOSES.\n\n    (a) Short Title.--This Act may be cited as the ``Medicare Home \nInfusion Therapy Act of 2001''.\n    (b) Purpose.--The purposes of this Act are to ensure that medicare \nbeneficiaries--\n            (1) have the choice of receiving infusion drug therapies in \n        the home when clinically appropriate rather than in an \n        inpatient setting; and\n            (2) are receiving high quality, safe, and efficient care \n        with respect to home infusion drug therapies.\n\nSEC. 2. COVERAGE OF AND PAYMENT FOR HOME INFUSION DRUG THERAPY \n              SERVICES.\n\n    (a) Coverage.--\n            (1) In general.--Section 1861(s) of the Social Security Act \n        (42 U.S.C. 1395x(s)) is amended--\n                    (A) in the second sentence, by redesignating \n                paragraphs (16) and (17) as clauses (i) and (ii); and\n                    (B) in the first sentence--\n                            (i) by striking ``and'' at the end of \n                        paragraph (14);\n                            (ii) by striking the period at the end of \n                        paragraph (15) and inserting ``; and''; and\n                            (iii) by adding after paragraph (15) the \n                        following new paragraph:\n            ``(16) home infusion drug therapy services (as defined in \n        subsection (ww).''.\n            (2) Conforming amendments.--Sections 1864(a) 1902(a)(9)(C), \n        and 1915(a)(1)(B)(ii)(I) of such Act (42 U.S.C. 1395aa(a), \n        1396a(a)(9)(C), and 1396n(a)(1)(B)(ii)(I)) are each amended by \n        striking ``paragraphs (16) and (17)'' each place it appears and \n        inserting ``clauses (i) and (ii) of the second sentence''.\n    (b) Home Infusion Drug Therapy Defined.--Section 1861 of such Act \n(42 U.S.C. 1395x), as amended by sections 102 and 105 of the Medicare, \nMedicaid, and SCHIP Benefits Improvement and Protection Act of 2000 \n(114 Stat. 2763A-468, 471), as enacted into law by section 1(a)(6) of \nPublic Law 106-554, is amended by adding at the end the following new \nsubsection:\n\n                 ``Home Infusion Drug Therapy Services\n\n    ``(ww)(1) The term `home infusion drug therapy services' means--\n            ``(A) pharmacy, nursing, and related items and services \n        (including medical supplies, intravenous fluids, drugs \n        described in section 1834(n), home delivery, equipment, and \n        other items and services the Secretary determines appropriate) \n        to administer infusion drug therapies to an individual safely \n        and effectively in the home in conformance with clinical \n        standards of care established by the Secretary;\n            ``(B) that are furnished by a qualified supplier via an \n        intravenous, intra-arterial or intrathecal access device \n        inserted into the body; and\n            ``(C) provided under a plan of care established and \n        periodically reviewed by a physician.\n    ``(2) In paragraph (1)--\n            ``(A) the term `home' means a place of residence used as an \n        individual's home (or a provider of services used as the \n        individual's home if the drug is administered during a period \n        of inpatient stay for which payment is not made to the provider \n        of services under part A); and\n            ``(B) the term `qualified supplier' means any entity that \n        meets such requirements as the Secretary determines are \n        necessary to ensure the safe and effective provision of home \n        infusion drug therapy services.''.\n    (c) Payment.--\n            (1) Establishment of fee schedule.--Section 1834 of the \n        Social Security Act (42 U.S.C. 1395l), as amended by section \n        223(b) of the Medicare, Medicaid, and SCHIP Benefits \n        Improvement and Protection Act of 2000 (114 Stat. 2763A-487), \n        as enacted into law by section 1(a)(6) of Public Law  106-554, \nis amended by adding at the end the following new subsection:\n    ``(n) Home Infusion Drug Therapy Services.--\n            ``(1) Establishment of fee schedule.-- The Secretary shall \n        establish by regulation before the beginning of 2002 and each \n        succeeding year a fee schedule for home infusion drug therapy \n        services for which payment is made under this part. In so \n        doing, the Secretary shall ensure the adequacy of aggregate \n        payments for the drug and nondrug components of home infusion \n        drug therapy, consistent with the requirements of paragraphs \n        (2) and (3).\n            ``(2) Requirements.--The Secretary shall ensure that the \n        coverage, reimbursement, and standards for covered home \n        infusion drug therapy services adequately reflect the various \n        components of care (including the services, drugs, supplies, \n        equipment, and related costs) necessary to ensure the safe and \n        effective provision of home infusion drug therapy. In so doing, \n        the Secretary shall--\n                    ``(A) take into account the definitions, \n                requirements, and clinical standards commonly used for \n                home infusion drug therapy by private health plans and \n                accrediting organizations;\n                    ``(B) ensure the adequacy of the aggregate payment \n                levels for home infusion drug therapy services, without \n                regard to whether payments for drug and nondrug \n                components are bundled or partially bundled by the \n                Secretary;\n                    ``(C) ensure that sufficient numbers of \n                geographically distributed and qualified home infusion \n                drug therapy providers participate in the part B \n                program so that enrolled beneficiaries have meaningful \n                access to home infusion drug therapy services provided \n                in accordance with the established quality of care \n                standards; and\n                    ``(D) consult with providers and trade associations \n                specializing in home infusion drug therapy.\n            ``(3) Publication of list of covered home infusion drugs.--\n        Not later than January 1, 2002 (and quarterly thereafter), the \n        Secretary shall publish a list of the drugs, and indications \n        for such drugs, that are covered home infusion drugs, with \n        respect to which home infusion drug therapy may be provided \n        under this title. This list shall include the following:\n                    ``(A) All intravenous antibiotic drugs unless the \n                Secretary has determined for a specific drug and \n                indication that the drug cannot generally be \n                administered safely and effectively in a home setting.\n                    ``(B) All infusion drug therapies requiring an \n                external infusion pump for safe and effective \n                administration that were, as of June 30, 2001, covered \n                by reason of 1861(s)(6).\n                    ``(C) Parenterally administered blood-derived \n                products.\n                    ``(D) Any other infusion drug for which the \n                Secretary has determined that, with respect to a \n                specific drug or the indication to which the drug is \n                applied, the drug can be administered safely and \n                effectively in the home (as defined in section \n                1861(ww)(2)(A).''.\n            (2) Conforming amendments.--(A) Section 1833(a)(1) of such \n        Act (42 U.S.C. 1395l(1)), as amended by sections 105(c) and \n        223(c) of the Medicare, Medicaid, and SCHIP Benefits \n        Improvement and Protection Act of 2000 (114 Stat. 2763A-YYY472, \n        489), as enacted into law by section 1(a)(6) of Public Law 106-\n        554, is amended--\n                    (i) by striking ``and (U)'' and inserting ``(U)''; \n                and\n                    (ii) by inserting before the semicolon at the end \n                the following: ``, and (V) with respect to home \n                infusion drug therapy services (as defined in section \n                1861(ww)(1)), the amounts paid shall be 80 percent of \n                the lesser of the actual charge or the amount \n                determined under the fee schedule established under \n                section 1834(n)''.\n            (B) The first sentence of section 1862(a) of such Act (42 \n        U.S.C. 1395y(a)) is amended--\n                    (i) by striking ``or'' at the end of paragraph \n                (20);\n                    (ii) by striking the period at the end of paragraph \n                (21) and inserting ``; or''; and\n                    (iii) by inserting after paragraph (21) the \n                following new paragraph:\n            ``(22) in the case of home infusion drug therapy services \n        under section 1861(ww)--\n                    ``(A) that are not furnished in the home (as \n                defined in paragraph (2)(A) of that section;\n                    ``(B) that do not meet the standards of clinical \n                care established by the Secretary;\n                    ``(C) that include drugs not listed under section \n                1834(n)(3);\n                    ``(D) that are items and services other than items \n                and services that Secretary determines appropriate \n                under that section; and\n                    ``(E) for which payment may be made under this \n                title other than under section 1833(a)(1)(V).''.\n    (d) Exclusion From Definition of Durable Medical Equipment.--\nSection 1861(n) of such Act (42 U.S.C. 1395x(n)) is amended by adding \nat the end the following: ``Such term does not include home infusion \ndrug therapy services (as defined in subsection (ww)).''.\n    (e) Effective Date.--The amendments made by this section shall \napply to items and services furnished on or after January 1, 2002. The \nSecretary shall publish a rule under this subsection in the Federal \nRegister by not later than the January 1, 2002. Such rule shall be \neffective and final immediately on an interim basis, but is subject to \nchange and revision after public notice and opportunity for a period \n(of not less than 60 days) for public comment."
}